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kstaines@rvc.ac.ukAbstractAberrant redeployment of the ‘transient’ events responsible for bone development and
postnatal longitudinal growth has been reported in some diseases in what is otherwise
inherently ‘stable’ cartilage. Lessons may be learnt from the molecular mechanisms
underpinning transient chondrocyte differentiation and function, and their application may
better identify disease aetiology. Here, we review the current evidence supporting this
possibility. We firstly outline endochondral ossification and the cellular and physiological
mechanisms by which it is controlled in the postnatal growth plate. We then compare the
biology of these transient cartilaginous structures to the inherently stable articular cartilage.
Finally, we highlight specific scenarios in which the redeployment of these embryonic
processes may contribute to disease development, with the foresight that deciphering those
mechanisms regulating pathological changes and loss of cartilage stability will aid future
research into effective disease-modifying therapies.Key Words
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.0 UJournal of Endocrinology
(2013) 219, R1–R12IntroductionThe transition of cartilage to bone is the basis by which all
long bones form. This transition is tightly regulated to
ensure both permissive foetal development through
endochondral ossification and postnatal longitudinal
growth at the epiphyseal growth plate. Tighter manage-
ment of these dynamic events may contribute to the
inherent stability of some cartilage, such as articular
cartilage, and this possibility is supported by emerging
evidence reporting the aberrant redeployment of these
transient events in the inherently stable cartilage in
several pathological states such as osteoarthritis. It is
therefore plausible that lessons can be realised from the
molecular mechanisms underpinning the physiological
transient chondrocyte differentiation and function. This
knowledge may help to decipher those mechanisms
surrounding joint pathology and ossification, and aid
future research into effective disease-modifying therapies.In this review, we discuss aspects of cartilage and bone
physiology, as well as the complex cellular processes
involved in the cartilage to bone transition during
endochondral ossification and at the postnatal growth
plate. Moreover, we will compare this transient cartilage
phenotype with the stable phenotype adopted by articular
chondrocytes in order to ostensibly safeguard their
permanence, and will discuss disease pathology in which
the aberrant redeployment of the transient phenotype
is observed.Transient cartilage
During mammalian embryological skeletal development,
the appendicular skeleton comprising the pectoral girdle,
pelvis and the limbs, arises from the lateral plate
mesoderm (Saito et al. 2006). These structures are formedsed under a Creative Commons
nported License.
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219 :1 R2by means of endochondral ossification as does much of
the axial skeleton including the vertebrae and ribs, which
arise from somites of paraxial mesoderm origin.
Ossification processes are regulated during embryolo-
gical development to produce the wide range of skeletal
forms that we see in different animal species. A major
challenge in skeletal morphogenesis is the precision of
growth regulation that is required to create functional
skeletal proportions, which can vary so widely between
species, and to produce paired skeletal elements which are
near identical in size. Therefore, there are major questions
in embryological skeletal development, including how do
condensations get to be the correct size and how is
directional growth achieved in limb patterning?
The apical ectodermal ridge and the zone of polarising
activity control proximo–distal and anterior–posterior
patterning in the growing limb bud. These two centres
are regulated by signalling pathways such as Indian
hedgehog (IHH) and WNT/b-catenin (reviewed elsewhere;
Summerbell et al. (1973), Kronenberg (2003), Tickle
(2003), Towers & Tickle (2009) and Wolpert (2010)).
Recent emerging evidence has suggested that planar cell
polarity, a non-canonical WNT pathway involving the
cadherins Fat and Dachsous (Fat/Dchs), is also important
in embryonic skeletal development (Goodrich & Strutt
2011). Gradients of Dchs expression appear to regulate cell
shape and directional movement during limb morpho-
genesis and growth (Dabdoub et al. 2003, Vladar et al.
2009, Wada & Okamoto 2009, Romereim & Dudley 2011).
There is also substantial evidence, from pharmacological
immobilisation of embryonic chicks, that movement-
induced mechanical bone loading regulates longitudinal
growth of skeletal elements (Osborne et al. 2002, Lamb
et al. 2003, Pitsillides 2006). Thus, mechanical stimuli may
exert epigenetic control over skeletal development to act
as an additional source of phenotypic variation during
development.Endochondral ossification
The majority of the skeleton is first formed during
embryonic development as cartilage anlagen; models of
future skeletal elements. The transient nature of this
cartilage is reflected in its eventual replacement by bone in
the fundamental process of endochondral ossification.
Endochondral ossification is initiated by embryonic
mesenchymal cells migrating to form pre-cartilage con-
densations, which then undergo differentiation into
chondrocytes and secrete an extracellular matrix rich in
collagen type II and aggrecan. The chondrocytes of thesehttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britaincartilage condensations undergo an ordered and highly
regulated process involving predominant marginal
proliferation and central maturation, hypertrophy and
cell death. These latter events define the framework of the
endochondral bone and are regulated by paracrine signals
including parathyroid hormone (PTH)-related peptide and
IHH from the perichondrium (Fig. 1; Storm & Kingsley
1996, Tickle & Mu¨nsterberg 2001, Wang et al. 2001,
Kronenberg 2003, Davey et al. 2006, Villavicencio-Lorini
et al. 2010, Mackie et al. 2011).
Primary ossification originates in the centre of the
diaphysis of the developing skeletal element. The growth
cartilage is invaded by blood vessels, seemingly attracted
by VEGF expression by hypertrophic chondrocyte (Zelzer
et al. 2002) and with this, infiltration of bone-resorbing
osteoclasts and bone-forming osteoblasts occurs. Further-
more, the perichondrium becomes vascularised around
the bone-forming element to create the periosteum. This
process of blood vessel invasion facilitated by degradation
of the calcified cartilage extracellular matrix around the
hypertrophic chondrocytes is critically reliant on the
activity of matrix metalloproteinase 13 (MMP13; Stickens
et al. 2004). Cartilage matrix resorption is followed by the
invasion of osteoblasts, which lay down the newly formed
bone. This process spreads longitudinally from the
primary ossification centre towards the ends of the bone.
Eventually, a secondary ossification centre forms, retain-
ing a cartilaginous growth plate between each epiphysis
and the primary ossification centre (Mackie et al. 2008).Morphology of the postnatal growth plate
The growth plate is a highly specialised developmental
region, responsible for postnatal linear bone growth. It
consists of chondrocytes, arranged in columns that
parallel the axis of the bone, surrounded by their matrix;
the precise composition of which is dependent upon the
state of chondrocyte differentiation (Fig. 1; Ballock &
O’Keefe 2003, Mackie et al. 2011). These chondrocytes
undergo a series of tightly regulated differentiation and
maturation processes, as is reflected by their changing
morphology and matrix production, whilst maintaining
their spatially fixed locations (Hunziker et al. 1987).
Interference with the maturational progression of
growth plate chondrocytes leads to abnormal cartilage
formation and ossification and modifications in the rates
of bone formation, for example, in rickets and dwarfism.
Details of the many syndromes and diseases and possible
therapeutic strategies are out with the scope of this reviewPublished by Bioscientifica Ltd
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Figure 1
Schematic representation depicting the proposed developmental origins of
articular and growth plate cartilage. Mesenchymal aggregation of
chondro-progenitors forms the cartilage anlagen and stages of chondro-
cyte proliferation (P, light blue), maturation (M, purple) and hypertrophy
(H, pink) emerge to provide the origins of the future ‘transient’
chondrocytes of the growth plate cartilage. Intervening regions of
progressively condensing mesenchyme define the interzone (I, yellow)
regions; the position of the future joint and origins of the ‘stable’ articular
cartilage chondrocytes. Images (right hand side) depicting the organisation
of the mature growth plate (lower) and articular cartilage (upper),
consisting of uncalcified cartilage zones (superficial (SZ), intermediate (IZ)
and deep (DZ)), and the related chondrocyte and collagen fibril
arrangement. The tidemark separates the non-calcified cartilage from
the calcified cartilage (CC) which overlies the subchondral bone (SB).
BarZ0.1 mm.
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219 :1 R3but have been the subject of discussion in other reviews
(Kornak & Mundlos 2003, Krakow & Rimoin 2010).
The primary zone of the growth plate, often known as
the ‘resting’ or ‘germinal’ zone, consists of undifferen-
tiated chondrocyte progenitors. Unlike the remainder of
the growth plate, the chondrocytes of the resting zone are
distributed sporadically and have a low rate of prolifer-
ation (Hunziker et al. 1987, Ballock & O’Keefe 2003,
Mackie et al. 2011). As chondrocytes progress from the
resting zone, they gain a proliferative phenotype and
adopt a flattened, oblate shape, arranging themselves into
longitudinal columns. It is proposed that the creation of
these highly organised columns is directed by the
chondrocytes in the resting zone, which have been
postulated to produce a growth plate-orientating factorhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britain(Hunziker et al. 1987, Abad et al. 2002). The high mitotic
activity of these proliferating chondrocytes is controlled
by numerous factors, including endocrine/autocrine
regulation, circadian rhythm and age. These chondrocytes
also undergo a period of high secretory activity as they
produce a collagen type-II- and proteoglycan-rich
matrix, which with some otherwise marked distinctions
closely resembles that seen in the articular cartilage
(Farnum et al. 2002).
The chondrocytes undergo major phenotypic changes
as they gradually become hypertrophic however, until
recently the mechanisms by which this occurs is unclear
but may involve membrane transporters in the chondro-
cyte membrane (Bush et al. 2008, 2010, Loqman et al.
2013). Furthermore, a paper by Cooper et al. has definedPublished by Bioscientifica Ltd
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219 :1 R4three distinct phases through which mammalian chon-
drocyte volume increases: i) true hypertrophy, indicating a
proportionate increase in dry mass production and fluid
uptake, responsible for approximately threefold increases
in volume, ii) a fourfold enlargement solely by cell
swelling and iii) a second distinct phase of true hyper-
trophy with proportionate dry mass and fluid volume
increases. These authors show that this final stage is
dependent upon insulin-like growth factor 1 (IGF1), a
well-recognised regulator of longitudinal bone growth and
chondrocyte hypertrophy (Wang et al. 1999, Ahmed &
Farquharson 2010, Cooper et al. 2013, Farquharson &
Ahmed 2013). More recent emerging evidence has detailed
the regulation of IGF1 signalling in chondrocyte hyper-
trophy by the WNT signalling pathway, more specifically
by WNT-induced secreted protein 3 (Rao et al. 2013).
Indeed, it appears that the WNT pathway is critical in
both growth plate and articular cartilage function, as we
have previously discussed in our recent review (Staines
et al. 2012a).
As well as changes in cell morphology, collagen type-II
expression decreases during chondrocyte maturation and
the hypertrophic chondrocyte initiates the synthesis of
collagen type-X (Schmid & Linsenmayer 1985, Kronen-
berg 2003). The matrix also includes chondrocalcin,
osteonectin and osteopontin, as well as having increased
membrane activity of alkaline phosphatase, indicating the
final maturation phase (Sommer et al. 1996, Shen 2005,
Roberts et al. 2007). Together these changes facilitate
mineralisation of the matrix, a complex process reliant
upon the levels of calcium and phosphate (Castagnola
et al. 1988). Mineralisation of the extracellular matrix also
enables vascular invasion, through which osteoclasts and
osteoblasts gain access via migration to replace the
cartilage template with bone (Gerber et al. 1999, Horner
et al. 1999, Engsig et al. 2000, Zelzer et al. 2002). Recent
evidence has suggested that the terminally differentiated
hypertrophic chondrocyte may sense signals that initiate
this transformation of the cartilage matrix into bony
trabeculae through the expression of receptor activator
of nuclear factor-kB ligand, an essential cytokine for
osteoclast development, function and survival (Xiong
et al. 2011).
The fate of the terminally differentiated chondrocyte
at the chondro-osseous junction is still a matter of debate.
However, it is well accepted that this chondrocyte does
require to be removed so as to maintain the steady-state
thickness of the growth plate. There has been significant
evidence to suggest that the chondrocytes die by
apoptosis and this appears the most accepted mechanismhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britain(Magne et al. 2003, Shapiro et al. 2005). Indeed the
activation of caspases and the decreased expression of
the anti-apoptotic factor, Bcl2, in the hypertrophic
chondrocytes certainly support this (Amling et al. 1997,
Adams & Shapiro 2002). The distinct lack of typical
apoptotic morphological changes in the terminal hyper-
trophic chondrocytes does, however, challenge this theory
(Emons et al. 2009, Carames et al. 2010). It would be
expected that the condensation of cellular chromatin and
the fragmentation of the cell nucleus would be visible,
associated with the eventual break down of the cell into
several vesicles which are then phagocytosed. Instead, the
presence of autophagic vacuoles and the expression of
autophagy-regulating genes by growth plate chondrocytes
suggest that these cells undergo processes more similar to
autophagy than apoptosis (Roach & Clarke 2000, Shapiro
et al. 2005). Furthermore, the transdifferentiation of
chondrocytes has also been proposed (Descalzi Cancedda
et al. 1995, Roach 1997). This involves the division of the
terminal hypertrophic chondrocyte to produce one
daughter cell which undergoes apoptosis and one which
transdifferentiates into an osteoblast phenotype. However
this theory has yet to be fully ratified and would certainly
benefit from experiments which use GFP-Cre systems to
track the collagen type-X expression of the hypertrophic
chondrocyte during its terminal fate.
Longitudinal bone growth occurs at the growth plate
until it closes once sexual maturity has been reached. This
is initiated through the formation of mineralised tethers
between epiphyseal and diaphyseal bone promoting the
fusion of the primary and secondary ossification centres
(Haines 1975). The chondrocytes of the growth plate reach
a state of senescence as they exhaust their proliferative
potential, and longitudinal bone growth is ceased. In
humans, oestrogen mediates these effects in both males
and females and the processes controlling fusion are
relevant to understanding the ‘permanent’ loss of this
transient chondrocyte phenotype (Nilsson et al. 2005,
Mackie et al. 2011).Stable cartilage
Articular cartilage formation
The earliest emergence of ‘stable’, articular cartilage
during skeletal patterning occurs with the formation of
interzones; regions of undifferentiated mesenchyme
which separate developing skeletal elements in which
the joint will later form. There has been some debate as to
whether individual skeletal elements are discrete from thePublished by Bioscientifica Ltd
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219 :1 R5outset of their development, or whether these elements
form from a single cartilage condensation which is later
divided by interzones (Fig. 1; Pitsillides & Ashhurst 2008).
Transient growth cartilage and articular cartilage differ
in their collagen composition during their development;
in embryonic growth cartilage, expression of collagen
type-IIA precedes collagen type-IIB expression, which is
not detectable at later stages of development. However in
articular cartilage, collagen type-IIA protein does not
appear in the interzones, which provides evidence for
the belief that the cartilage anlagen that form individual
skeletal elements are not continuous (Ng et al. 1993,
Pitsillides & Ashhurst 2008). This suggests that the
populations of cells which will become the growth and
articular cartilage chondrocytes are discrete. Evidence for
these discrete origins is also provided by the GDF5-
mediated tracking of interzonal cells, and by the unique
expression of versican, an extracellular matrix proteogly-
can, in the regions of the presumptive articular cartilage in
joint morphogenesis (Pacifici et al. 2005, 2006, Snow et al.
2005, Hyde et al. 2007).
Interzones first appear as densely cellular, hom-
ogenous regions with GDF5, WNT9A, autotaxin and
chordin being known as interzone markers (Pacifici et al.
2005). Non-canonical WNT9A signalling is particularly
important early in development as it acts to inhibit
chondrocyte differentiation at the presumptive joint site
(Hartmann & Tabin 2001). As joint development pro-
gresses, the interzone differentiates into three recognisable
layers: two chondrogenic layers which cover the articular
surfaces of the developing opposed skeletal elements and
an intermediate layer which separates them. There is
evidence to suggest that the cells derived from this
intermediate layer differentiate to become articular chon-
drocytes, while the outer layer chondrocytes are incorpor-
ated into the growing epiphysis (Ito & Kida 2000).
Joint cavity formation is thought to occur due to a
combination of extrinsic mechanical factors and intrinsic
factors. Cell death is not thought to be primarily
responsible for the formation of the joint cleft; rather,
changes in extracellular matrix composition including
hyaluronan synthesis, mediated by mechanical activation
of the MEK–ERK pathway, which result in a loss of tissue
cohesion have been implicated (Archer et al. 1994, Ito &
Kida 2000, Bastow et al. 2005).Articular cartilage phenotype
Fully developed uncalcified articular cartilage can be
divided into superficial, intermediate and deep zoneshttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britain(Fig. 1). These different zones consist of just one cell
type, the chondrocyte. These chondrocytes differ from the
transient growth plate chondrocytes as they maintain a
stable phenotype characterised by small cell size and
expression of tenascin-C, and they do not undergo a
sequence of proliferation, maturation, hypertrophy,
apoptosis and ossification (Pacifici et al. 2005, 2006). It
has been suggested that the expression of the transcription
factor ETS-related gene (ERG) is necessary early in joint
development to establish the articular chondrocyte
phenotype (Pacifici et al. 2006). It is the organisation of
cells and their collagen type-II and aggrecan-richmatrix in
the differing zones, however, which makes them distinct
from one another. Whilst the superficial zone consists of
elongated chondrocytes orientated parallel to the surface
of the cartilage, chondrocytes in the deep zone are more
rounded and aligned along the collagen fibrils. The
collagen fibrils in the intermediate zone of the articular
cartilage are arranged in arches which allow the transition
from thedeep and superficial zones (Minns&Steven1977).
The deep zone of the articular cartilage forms an
interface, termed the tidemark, with calcified cartilage
which forms through mechanisms that are not quite
understood. Within this calcified cartilage, the chondro-
cytes are hypertrophic and this is accompanied by their
expression of collagen type-X and alkaline phosphatase
(Heinegard & Oldberg 1989, Gannon et al. 1991, Stephens
et al. 1992). Therefore, despite the cellular singularity and
stability of the articular cartilage chondrocyte, there is
some degree of transiency due to the varying chondrocyte
phenotypes which exist within the entirety of the tissue.
This notion is supported by the presence of chondrocyte
progenitors in the superficial zone both at young stages
of development and in the mature cartilage (Dowthwaite
et al. 2004). Therefore tighter management of these
dynamic events, although much slower than those in
the growth plate, may alone underpin the maintenance of
the articular cartilage stability.
The calcified cartilage layer is semipermeable and
whilst it acts as a physical barrier for vascular invasion of
the overlying articular cartilage, it does permit the passage
of small molecules from the underlying subchondral bone
(Arkill &Winlove 2008). In humans, the calcified cartilage
thickness varies widely, fromw20 to 250 mmhowever, like
the tidemark, this a dynamic structure which can be
remodelled during ageing and disease, as highlighted
by observed morphological changes in osteoarthritis
including tidemark duplication and increased calcified
cartilage thickness (Lane & Bullough 1980, Oettmeier et al.
1989, Oegema et al. 1997, Hunziker et al. 2002, Burr 2004).Published by Bioscientifica Ltd
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osteochondral interface are yet to be fully defined. Their
identification may provide potential targets for thera-
peutic intervention.The ectopic initiation of cartilage–bone
transitions
The transition of cartilage to bone in the healthy
individual is under tight regulation so as to prevent
disturbed development and/or longitudinal bone growth.
Observations from disorders such as hypothyroidism,
rickets and dwarfism may provide insights into the
mechanisms underpinning defective hypertrophic differ-
entiation and ossification (Combs et al. 2011, Santos et al.
2013). Regulation is also observed in repair of fractured
bone tissue, in which there is a deliberate re-initiation of
the endochondral processes (see above) previously dis-
cussed in this review. There has been much recent focus
upon the WNT signalling pathway in fracture repair and,
in particular, the recent discovery of enhanced repair
through the administration of neutralizing antibodies
against sclerostin, a known WNT inhibitor (Secreto et al.
2009, Ominsky et al. 2011, Virk et al. 2013). In contrast to
this desired acceleration in endochondral ossification
processes, in certain diseases the ectopic redeployment
of these processes is detrimental and considered to be
at least contributory to the observed disease pathology.
Herein we discuss conditions in which this occurs and
touch upon current understanding regarding the role of
these processes in their aetiology.Osteoarthritis
Osteoarthritis is a degenerative joint disease and a massive
world-wide healthcare burden. Characterised by articular
cartilage loss, subchondral bone thickening and osteo-
phyte formation, the osteoarthritic joint afflicts much
pain and disability on its sufferers. Its underpinning
molecular mechanisms are, nevertheless, not fully under-
stood; indeed it is even still a matter of debate as to which
is the preceding pathology. However, there is increasing
evidence implicating the re-initiation of the transient
chondrocyte phenotype in osteoarthritic aetiology and
pathology (Fosang & Beier 2011, Pitsillides & Beier
2011; Fig. 2). This notion is based upon the previously
discussed common embryonic development of cartilage
and bone and the current evidence certainly merits
thorough examination. However, it has been met
with some controversy in the field (Brew et al. 2010).http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great BritainSuch controversies may potentially be addressed through a
better understanding of the articular cartilage volume to
surface area ratios in different species, and thus may
provide some explanation as to why the degree of
chondrocyte transiency in the articular cartilage differs
from species to species.
In osteoarthritic cartilage, there have been observed
decreases in collagen type-II and aggrecan integrity in
comparison to normal articular cartilage (Helminen et al.
1993, Garnero et al. 2002, Jalba et al. 2011, Henrotin et al.
2013). Furthermore, markers previously thought to be
unique to the hypertrophic chondrocytes of the growth
plate have been detected in the uncalcified articular
cartilage in both animal models of osteoarthritis, and in
patients with the disease. The best recognised of these are
MMP13 and collagen type-X, however, also detected are
alkaline phosphatase, osteopontin, IHH and osteocalcin
(Hoyland et al. 1991, Aigner et al. 1993, Pullig et al. 2000,
Appleton et al. 2007, Studer et al. 2012). As in the transient
growth plate cartilage, chondrocyte hypertrophy is
considered to be a prerequisite for matrix mineralisation
and in osteoarthritis, the increased formation of hydro-
xyapatite has been documented and is consistent with
hypertrophic chondrocyte changes (Fuerst et al. 2009).
MMP13, a key marker of chondrocyte hypertrophy, is
proving a critical target in osteoarthritis research due to
its potent role in the degradation of collagen type-II,
proteoglycans, collagen types-IV and IX, osteonectin and
perlecan (Wang et al. 2013). Indeed, Mmp13-deficient
mice predictably have an endochondral bone growth
defect with an expanded hypertrophic chondrocyte zone
which was not attributable to increased chondrocyte
proliferation, increased proteoglycan turnover and
increased trabecular bone (Stickens et al. 2004). Never-
theless, whilst the surgical induction of osteoarthritis in
this mouse causes chondrocyte hypertrophy and osteo-
phyte formation, the graded score of cartilage degradation
was intriguingly significantly reduced (Little et al. 1999).
Deletion of the Mmp13 gene specifically in chondrocytes
also produces similar deceleration of osteoarthritis disease
progression following meniscal-ligamentous injury in a
mouse model (Wang et al. 2013). Consistent with this
crucial role for Mmp13, its overexpression was also found
to result in pathological osteoarthritis-like changes in the
articular cartilage of mice (Neuhold et al. 2001). Recent
research has implicated the WNT signalling pathway and
its inhibitors as important regulators of MMP13 (van den
Bosch et al. 2013, Chan et al. 2013, Staines et al. 2013),
which is consistent with critical WNT function in thePublished by Bioscientifica Ltd
Healthy articular joint Osteoarthritic joint
Articular
cartilage
Calcified
cartilage
Subchondral
bone
Articular chondrocyte
Osteocyte
Hypertrophic chondrocyte
Matrix factors
MMP13
Coll X
RUNX2
Matrilin-1
VEGF
Doublecortin
Versican
Signalling factors
Notch
Wnt/β-catenin
TGF-β
Sox-5/-6/-9
GDF5
HIF-2a
Hh
Mineralisation
Alpl
Enppl
Phosphol
Mepe
Sclerostin
Figure 2
Schematic diagram depicting the healthy articular joint and the
osteoarthritic joint in which articular cartilage fibrillation and degradation
is observed with concomitant subchondral bone thickening. Contributing
to this osteoarthritic pathology, the normally ‘stable’ articular chondro-
cytes of the articular cartilage adopt a ‘transient’ phenotype with observed
chondrocyte hypertrophy and matrix mineralisation similar to that seen
in the growth cartilage depicted in Fig. 1. Potential regulation of these
processes may include changes in the expression of matrix factors
(blue box; factors induced in osteoarthritis development in black, factors
lost in red), signalling pathways affecting chondrocyte phenotype and
function (yellow box) and the known regulators of mineralisation
processes (purple box) (Grover & Roughley 1993, Pacifici et al. 2006, Zhang
et al. 2007, Fosang & Beier 2011, Pitsillides & Beier 2011, Staines et al.
2012b). Lessons may be learnt from these and their application may better
identify disease aetiology.Jo
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Miclea et al. 2011).
Epigenetics has been strongly implicated in osteo-
arthritis in recent years with all three currently known
mechanisms – DNA methylation, histone modifications
and non-coding RNAs – demonstrate a capacity to control
the chondrocyte phenotype. This too has highlighted a
role for MMP13. More specifically, MMP13 promotor
methylation is altered in osteoarthritic cartilage,
suggesting that these epigenetic changes can therefore
drive the chondrocyte hypertrophy observed in the
pathological state (Roach et al. 2005). It should be noted
that the precise initiation and control of these events is yet
to be established. However, with the surge in epigenetic
studies in recent years, it is certainly an exciting and
promising time for this field.
This evidence therefore pinpoints the need to deci-
pher the molecular mechanisms underpinning the
recapitulation of some of these developmental ‘hallmarks’
by articular cartilage chondrocytes in osteoarthritis. It ishttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
 2013 The authors
Printed in Great Britainenvisaged that this will undoubtedly advance under-
standing into disease pathology and might ultimately
define whether the pathogenic pathways in osteoarthritis
can be prevented by regulating the stability of chondro-
cytes by limiting acquisition of their transient, growth-
related phenotype.
Certainly the field of tissue engineering would benefit
from such understanding. Combining the use of cells and
biomaterials, this approach has emerged as a promising
target for cartilage repair. The first repair of cartilage
defects was described in 1994 and used autologous
chondrocytes (Brittberg et al. 1994). Despite the limi-
tations associated with this, including the need to disrupt
healthy cartilage and problems with culturing chondro-
cytes, its emergence has certainly set the platform from
which cartilage tissue engineering has greatly progressed
in recent years. The use of human mesenchymal stem
cells, with their ability to overcome the limitations
defined by the use of chondrocytes, has been repeatedly
reported in osteoarthritis as a means of providing promisePublished by Bioscientifica Ltd
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et al. 2010). It has become apparent that human
mesenchymal stem cells can also gain expression of the
chondrocyte hypertrophy marker, collagen type-X, and
it is clear that this still limits their effectiveness as a
candidate for tissue engineering. Indeed, a recent study
has shown that mesenchymal stem cells express higher
levels of the genes associated with osteoarthritis, upon
culture, than do chondrocytes derived from the osteo-
arthritic joints themselves (Mwale et al. 2010, Fernandes
et al. 2013).Intervertebral disc calcification
Intervertebral disc (IVD) degeneration is a major cause of
back pain worldwide with complex, expensive surgery
which is often prone to failure (Urban & Roberts 1995).
Located between the vertebral bodies of the spine, the
cartilaginous IVD functions to resist compressive loads
(Broberg 1983). Anatomically, it consists of a central
nucleus pulposus contained within a fibrocartilage ring,
the annulus fibrosus, laterally and the cartilage end plates
inferiorly and superiorly (Roberts et al. 2006). The nucleus
pulposus shares many similarities with articular cartilage,
both in its matrix composition and its cellular metabolism
(Raj 2008). Associated with ageing and with abnormal
mechanical loading playing a substantial role, the
pathogenesis of IVD degeneration is yet to be fully
elucidated. There is, however, emerging evidence for the
occurrence of hypertrophic differentiation in this process.
The IVDs of patients with degenerative disc disease
have increased alkaline phosphatase activity, and also in
contrast to healthy IVDs express significant levels of
hypertrophic differentiation markers, including collagen
type-X, osteoprotegerin (OPG), MMP13 and RUNX2 (Boos
et al. 1997, Nerlich et al. 1997, Sato et al. 2008, Rutges et al.
2010, Hristova et al. 2011). Associated with this, microCT
analysis clearly shows increased levels of IVD calcification
with increasing degeneration (Rutges et al. 2010). A recent
in vitro study has sought to examine the mineralisation
potential of the cells of the annulus fibrosus, and
concluded that under certain conditions these cells can
induce mineralisation, as indicated by their increased von
Kossa staining, alkaline phosphatase, MMP13 and RUNX2
expression (Nosikova et al. 2013).
Understanding of the mechanisms supporting
induction of such hypertrophy in IVD cells is somewhat
lacking. However, it was shown recently that PTH can
enhance disc repair through its inhibition of collagen
type-X and alkaline phosphatase expression, and throughhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0276
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Printed in Great Britainthe promotion of collagen type-II production. These
regenerative properties of PTH are mediated through
MAPK signalling (Madiraju et al. 2013). The authors of
this study suggest that PTH supplementation may prevent
further calcification in degenerated discs and potentially
enhance other cell-based therapies. This is certainly
promising due to the known critical role for PTH
signalling in chondrocyte hypertrophy and matrix min-
eralisation (Mackie et al. 2011, Yano et al. 2013). The
current major problem hindering IVD tissue engineering,
like in osteoarthritis, is the undesirable expression of
collagen type-X by human mesenchymal stem cells.
Recent studies have highlighted that PTH treatment can
also inhibit such misexpression and may thus open
additional avenues for the treatment of degenerative
IVDs with mesenchymal stem cells (Mwale et al. 2010).Heterotopic ossification
Heterotopic ossification (HO) is a common occurrence in
muscle, tendon and ligaments following trauma by injury,
disease or surgery. Initiated by cartilage formation, the
endochondral ossification and ectopic bone formation in
these tissues can produce severe functional impairment
(Medici & Olsen 2012).
Besides the trauma-induced HO described, a rare
disease called fibrodysplasia ossificans progressiva (FOP)
is a hereditary form of HO, presenting itself as painful and
highly inflammatory soft tissue swellings which pro-
gressively ossify rendering the sufferer immobile (Cohen
et al. 1993, Shore et al. 2006, Medici & Olsen 2012). Like
in trauma-induced HO, the aberrant bone formation in
patients with FOP occurs by means of endochondral
ossification processes. Emerging evidence has strongly
implicated increased bone morphogenetic protein (BMP)
signalling in the pathogenesis of FOP, as well as in trauma-
induced HO (Cohen et al. 1993, Kwapisz et al. 2013). The
identification of ACVR1/ALK2, one of the four type-I
receptors that mediate BMP signalling, as the mutated
gene in FOP in 2006 has further highlighted the BMP
signalling pathway as an attractive target for future
therapy (Shore et al. 2006).Conclusions
The aberrant redeployment of embryonic processes in
diseases such as osteoarthritis and IVD degeneration is
now well established. Emerging evidence has further
fuelled the hypothesis that lessons for limiting disease
progression can be acquired from the regulators ofPublished by Bioscientifica Ltd
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review provides some pointers as to potential targets for
future drug therapies or tissue engineering approaches
which will further our understanding of the underpinning
molecular mechanisms involved in these diseases, and will
provide advances towards patient benefit.Declaration of interest
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